Desk› Healthcare› Valiant Laboratories Ltd

Valiant Laboratories Ltd

BSE 543998 VALIANTLAB INE0JWS01017

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

11 filings · 4 material · busiest 2026-08-10

What it files

Newspaper Publication1 Board Outcome1 Results1 Change in Directorate1 Acquisition1 Registered Office1 General1 Monitoring Agency1

Filings

11 in the window

12 August 2026

Newspaper Publication

Newspaper Publication

Copy of Newspaper Publication of Financial Results for the quarter ended June 30, 2026.

Company Update / Newspaper Publication View filing →
10 August 2026

Board Outcome

Board Meeting Outcome for Audited Standalone And Consolidated Financial Results For Quarter Ended June 30, 2026.

Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.

Board Meeting / Outcome of Board Meeting View filing →
10 August 2026

Results

For Quarter Ended June 30, 2026.

Audited Standalone and Consolidated Financial Results for quarter ended June 30, 2026.

Result / Financial Results View filing →
10 August 2026

Change in Directorate

Change in Directorate

Re-appointment of Managing Director, Independent Director and Continuation of Directorship of Non- Executive Director.

Company Update / Change in Directorate View filing →
10 August 2026

Acquisition

Acquisition

Investment in Wholly Owned Subsidiary.

Company Update / Acquisition View filing →
10 August 2026

Registered Office

Change in Registered Office Address

Change in the Registered Office address of the Company, subject to the approval of shareholders and other Statutory Authorities.

Company Update / Change in Registered Office Address View filing →
10 August 2026

General

Opening Of A New Corporate Office Of The Company

Opening of a new Corporate Office of the Company

Company Update / General View filing →
10 August 2026

Monitoring Agency

Monitoring Agency Report

Monitoring Agency Report for the quarter ended June 30, 2026

Company Update / Monitoring Agency Report View filing →
5 August 2026

Board Meeting

Board Meeting Intimation for Approval Of Financial Results For Quarter Ended June 30, 2026

Valiant Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve financial results for ....

Board Meeting / Board Meeting View filing →
13 July 2026

Compliance Certificate

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

for quarter ended June 30, 2026.

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
26 June 2026

Trading Window

Closure of Trading Window

Closure of Trading Window for declaration of Financial Results for the quarter ended June 30, 2026.

Insider Trading / SAST / Closure of Trading Window View filing →